IRADIMED Announces 2018 Annual and First Quarter Financial Guidance

IRADIMED (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging medical devices and the only known provider of a non-magnetic intravenous infusion pump system that is designed to be safe for use during MRI procedures, today announced its financial guidance for the full year and first quarter 2018.
As quoted in the press release:

“With growing momentum in customer orders for our IV pump and a solid start for our new MRI compatible patient vital signs monitor, which was FDA 510(k) cleared during the fourth quarter, we are looking forward to a strong 2018,” said Roger Susi, President and Chief Executive Officer of the Company

Click here to read the full press release.